These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 21196254)

  • 41. Expression Patterns of Cancer Stem Cell Markers During Specific Celecoxib Therapy in Multistep Rat Colon Carcinogenesis Bioassays.
    Salim EI; Hegazi MM; Kang JS; Helmy HM
    Asian Pac J Cancer Prev; 2016; 17(3):1023-35. PubMed ID: 27039721
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunohistochemical detection of cancer stem cell related markers CD44 and CD133 in metastatic colorectal cancer patients.
    Pitule P; Cedikova M; Daum O; Vojtisek J; Vycital O; Hosek P; Treska V; Hes O; Kralickova M; Liska V
    Biomed Res Int; 2014; 2014():432139. PubMed ID: 24864242
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Isolation and propagation of a human CD133(-) colon tumor-derived cell line with tumorigenic and angiogenic properties.
    Navarro-Alvarez N; Kondo E; Kawamoto H; Hassan W; Yuasa T; Kubota Y; Seita M; Nakahara H; Hayashi T; Nishikawa Y; Hassan RA; Javed SM; Noguchi H; Matsumoto S; Nakaji S; Tanaka N; Kobayashi N; Soto-Gutierrez A
    Cell Transplant; 2010; 19(6):865-77. PubMed ID: 20587145
    [TBL] [Abstract][Full Text] [Related]  

  • 44. STAT3 signaling pathway is necessary for cell survival and tumorsphere forming capacity in ALDH⁺/CD133⁺ stem cell-like human colon cancer cells.
    Lin L; Fuchs J; Li C; Olson V; Bekaii-Saab T; Lin J
    Biochem Biophys Res Commun; 2011 Dec; 416(3-4):246-51. PubMed ID: 22074823
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Subpopulation of small-cell lung cancer cells expressing CD133 and CD87 show resistance to chemotherapy.
    Kubo T; Takigawa N; Osawa M; Harada D; Ninomiya T; Ochi N; Ichihara E; Yamane H; Tanimoto M; Kiura K
    Cancer Sci; 2013 Jan; 104(1):78-84. PubMed ID: 23066953
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The prognostic significance of aldehyde dehydrogenase 1A1 (ALDH1A1) and CD133 expression in early stage non-small cell lung cancer.
    Alamgeer M; Ganju V; Szczepny A; Russell PA; Prodanovic Z; Kumar B; Wainer Z; Brown T; Schneider-Kolsky M; Conron M; Wright G; Watkins DN
    Thorax; 2013 Dec; 68(12):1095-104. PubMed ID: 23878161
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The cancer stem cell marker CD133 has high prognostic impact but unknown functional relevance for the metastasis of human colon cancer.
    Horst D; Scheel SK; Liebmann S; Neumann J; Maatz S; Kirchner T; Jung A
    J Pathol; 2009 Dec; 219(4):427-34. PubMed ID: 19621338
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of cancer stem cells from different grades of human colorectal cancer.
    Manhas J; Bhattacharya A; Agrawal SK; Gupta B; Das P; Deo SV; Pal S; Sen S
    Tumour Biol; 2016 Oct; 37(10):14069-14081. PubMed ID: 27507615
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cancer stem-like cells in human prostate carcinoma cells DU145: the seeds of the cell line?
    Wei C; Guomin W; Yujun L; Ruizhe Q
    Cancer Biol Ther; 2007 May; 6(5):763-8. PubMed ID: 17592251
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CD133+CD44+ population efficiently enriches colon cancer initiating cells.
    Haraguchi N; Ohkuma M; Sakashita H; Matsuzaki S; Tanaka F; Mimori K; Kamohara Y; Inoue H; Mori M
    Ann Surg Oncol; 2008 Oct; 15(10):2927-33. PubMed ID: 18663533
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment.
    Bertolini G; Roz L; Perego P; Tortoreto M; Fontanella E; Gatti L; Pratesi G; Fabbri A; Andriani F; Tinelli S; Roz E; Caserini R; Lo Vullo S; Camerini T; Mariani L; Delia D; Calabrò E; Pastorino U; Sozzi G
    Proc Natl Acad Sci U S A; 2009 Sep; 106(38):16281-6. PubMed ID: 19805294
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prostate cancer stem cells: from theory to practice.
    Adamowicz J; Pakravan K; Bakhshinejad B; Drewa T; Babashah S
    Scand J Urol; 2017 Apr; 51(2):95-106. PubMed ID: 28635565
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CD133 and CD44 are universally overexpressed in GIST and do not represent cancer stem cell markers.
    Chen J; Guo T; Zhang L; Qin LX; Singer S; Maki RG; Taguchi T; Dematteo R; Besmer P; Antonescu CR
    Genes Chromosomes Cancer; 2012 Feb; 51(2):186-95. PubMed ID: 22076958
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differential expression of CD133 based on microsatellite instability status in human colorectal cancer.
    Park JJ; Kwon JH; Oh SH; Choi J; Moon CM; Ahn JB; Hong SP; Cheon JH; Kim TI; Kim H; Kim WH
    Mol Carcinog; 2014 Feb; 53 Suppl 1():E1-10. PubMed ID: 23065858
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cancer stem cells in lung cancer: Evidence and controversies.
    Alamgeer M; Peacock CD; Matsui W; Ganju V; Watkins DN
    Respirology; 2013 Jul; 18(5):757-64. PubMed ID: 23586700
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of the intestinal cancer stem cell marker CD166 in the human and mouse gastrointestinal tract.
    Levin TG; Powell AE; Davies PS; Silk AD; Dismuke AD; Anderson EC; Swain JR; Wong MH
    Gastroenterology; 2010 Dec; 139(6):2072-2082.e5. PubMed ID: 20826154
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sequential expression of putative stem cell markers in gastric carcinogenesis.
    Wang T; Ong CW; Shi J; Srivastava S; Yan B; Cheng CL; Yong WP; Chan SL; Yeoh KG; Iacopetta B; Salto-Tellez M
    Br J Cancer; 2011 Aug; 105(5):658-65. PubMed ID: 21829201
    [TBL] [Abstract][Full Text] [Related]  

  • 58. FOXM1-Induced PRX3 Regulates Stemness and Survival of Colon Cancer Cells via Maintenance of Mitochondrial Function.
    Song IS; Jeong YJ; Jeong SH; Heo HJ; Kim HK; Bae KB; Park YH; Kim SU; Kim JM; Kim N; Ko KS; Rhee BD; Han J
    Gastroenterology; 2015 Oct; 149(4):1006-16.e9. PubMed ID: 26091938
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Generation and characterisation of cisplatin-resistant non-small cell lung cancer cell lines displaying a stem-like signature.
    Barr MP; Gray SG; Hoffmann AC; Hilger RA; Thomale J; O'Flaherty JD; Fennell DA; Richard D; O'Leary JJ; O'Byrne KJ
    PLoS One; 2013; 8(1):e54193. PubMed ID: 23349823
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Coexpression of CD44-positive/CD133-positive cancer stem cells and CD204-positive tumor-associated macrophages is a predictor of survival in pancreatic ductal adenocarcinoma.
    Hou YC; Chao YJ; Tung HL; Wang HC; Shan YS
    Cancer; 2014 Sep; 120(17):2766-77. PubMed ID: 24839953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.